NYSE: HUNHuntsman Corp Stock
$13.70-0.61 (-4.26%)
Updated May 15, 2026
HUN Price
$13.70
Fair Value Price
N/A
Market Cap
$2.40B
52 Week Low
$7.30
52 Week High
$15.85
P/E
-7.1x
P/B
0.9x
P/S
0.4x
PEG
N/A
Dividend Yield
4.93%
Revenue
$5.69B
Earnings
-$332.00M
Gross Margin
12.9%
Operating Margin
-4.02%
Profit Margin
-5.8%
Debt to Equity
1.58
Operating Cash Flow
$310M
Beta
1.09
Next Earnings
N/A
Ex-Dividend
Jun 15, 2026
Next Dividend
Jun 30, 2026
HUN Overview
Huntsman Corporation manufactures assorted polyurethanes, performance products, and adhesives for customers like BMW, GE, Chevron, Procter & Gamble, Unilever, and Walkaroo. The company operates manufacturing, R&D, and operations facilities in the U.S. and internationally. Huntsman was founded in 1970 and is headquartered in The Woodlands, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HUN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Chemical
Industry Rating
C
HUN
Ranked#9 of 15
Ranked#9 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $22.65 | A | |
| $17.14 | A | |
| $14.50 | A |
Be the first to know about important HUN news, forecast changes, insider trades & much more!
HUN News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HUN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HUN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HUN is good value based on its book value relative to its share price (0.9x), compared to the US Chemicals industry average (1.91x)
P/B vs Industry Valuation
HUN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more HUN due diligence checks available for Premium users.
Valuation
HUN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-7.1x
Industry
-18.86x
Market
22.65x
HUN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.9x
Industry
1.91x
HUN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HUN's financial health
Profit margin
Revenue
$1.4B
Net Income
-$53.0M
Profit Margin
-3.7%
HUN's Earnings (EBIT) of -$229.00M... subscribe to Premium to read more.
Interest Coverage Financials
HUN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$7.1B
Liabilities
$4.2B
Debt to equity
1.58
HUN's short-term assets ($2.18B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HUN's long-term liabilities ($2.51B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HUN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HUN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$53.0M
Investing
-$37.0M
Financing
$30.0M
HUN's operating cash flow ($310.00M)... subscribe to Premium to read more.
Debt Coverage Financials
HUN vs Chemical Stocks
Huntsman Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.